聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 9 分钟 19 秒 前

Breg And United Orthopedic Group Announce Merger

周三, 10/15/2014 - 16:42
Combination Creates a Leading U.S. Provider of Sports Medicine and Rehabilitative Orthopedic Products and Services CARLSBAD, Calif. and PLANO, Texas, Oct. 15, 2014 -- (Healthcare Sales & Marketing Network) -- Breg, Inc. and United Orthopedic Group, Inc...
Devices, Orthopaedic, Mergers & Acquisitions
Breg , United Orthopedic Group

SafeWire(R), Inc. Receives CE Mark Certification for Y-Wire(R) Anchoring Guide Wire

周三, 10/15/2014 - 16:38
Unique Bifurcated Guidewire Designed to Prevent Injuries & Reduce Fluoroscopy COOPER CITY, Fla., Oct. 15, 2014 -- (Healthcare Sales & Marketing Network) -- SafeWire®, LLC., a medical device company focused on safety and cost efficiency in pedicle s...
Devices, Orthopaedic, Neurosurgery, Regulatory
SafeWire, Y-Wire, pedicle screw

Navidea Announces Rick Gonzalez as New Chief Executive Officer

周三, 10/15/2014 - 16:34
DUBLIN, Ohio--(Healthcare Sales & Marketing Network)--Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Rick Gonzalez has been appointed Chief Executive ...
Biopharmaceuticals, Diagnostics, Personnel
Navidea Biopharmaceuticals, Lymphoseek

Selecta Announces More than $20 Million in Equity Funding

周三, 10/15/2014 - 16:27
WATERTOWN, Mass.--(Healthcare Sales & Marketing Network)--Selecta Biosciences, Inc., a clinical stage biotechnology company developing a novel class of targeted antigen-specific immune therapies, today announced it has secured equity funding of more than $...
Biopharmaceuticals, Venture Capital
Selecta Biosciences, Synthetic Vaccine Particle

Capricor Therapeutics Announces Acquisition of Intellectual Property Rights to Family of Natriuretic Peptides From Medtronic, Inc.

周二, 10/14/2014 - 14:57
LOS ANGELES, Oct. 14, 2014 -- (Healthcare Sales & Marketing Network) -- Capricor Therapeutics, Inc. (CAPR), a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases, today announced that it has entered i...
Biopharmaceuticals, Devices, Cardiology, Acquisitions
Capricor Therapeutics, Medtronic, natriuretic peptides, Cenderitide

Spine Wave Announces the Full Commercial Launch of the Lateral Access Product Portfolio

周二, 10/14/2014 - 14:53
The Lateral Access Product Portfolio Now Includes the StaXx(R) IBL Expandable Interbody Device, the Abacus(TM) Lateral Spacer System and the XLR(R) Lateral Access System SHELTON, CT--(Healthcare Sales & Marketing Network) - Spine Wave, Inc. is a medical...
Devices, Orthopaedic, Neurosurgery, Product Launch
Spine Wave, Lateral Access, StaXx, Interbody

FDA Approves VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older

周一, 10/13/2014 - 13:13
SARATOGA, Calif., Oct. 13, 2014 -- (Healthcare Sales & Marketing Network) -- VisionCare Ophthalmic Technologies, Inc. ("VisionCare"), a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), ...
Devices, Ophthalmology, FDA
VisionCare Ophthalmic Technologies, telescope implant, macular degeneration

FDA Approves AKYNZEO(R) (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV)

周一, 10/13/2014 - 13:08
First New Fixed Combination Targeting Two Critical Pathways Involved in CINV LUGANO, Switzerland and WOODCLIFF LAKE, N.J., Oct. 13, 2014 -- (Healthcare Sales & Marketing Network) -- Helsinn Group and Eisai Inc. announced today that the Food and Drug Ad...
Biopharmaceuticals, FDA
Eisai, Helsinn Group, AKYNZEO, CINV

VEXIM to Initiate Clinical Study to Support Planned 510(k) Application to Market SpineJack(R) in the United States

周一, 10/13/2014 - 12:56
Safety and effectiveness of SpineJack® will be compared with balloon kyphoplasty in 150 patients in Europe TOULOUSE, France--(Healthcare Sales & Marketing Network)--VEXIM (ALVXM.PA) (FR0011072602 – ALVXM / Eligible PEA-PME), a medical device company...
Devices, Neurosurgery, Orthopaedic
VEXIM , SpineJack, vertebroplasty, kyphoplasty

Regado Biosciences Appoints Michael A. Metzger CEO

周五, 10/10/2014 - 13:30
BASKING RIDGE, N.J., Oct. 10, 2014 -- (Healthcare Sales & Marketing Network) -- Regado Biosciences, Inc. (RGDO), today announced the appointment of Michael A. Metzger, president of Regado, to the additional post of chief executive officer and as a member ...
Biopharmaceuticals, Personnel
Regado Biosciences, Revolixys

Aymeric Le Chatelier joins Ipsen as Executive Vice President, Chief Financial Officer

周五, 10/10/2014 - 13:21
PARIS--(Healthcare Sales & Marketing Network)--Ipsen (Euronext: IPN; ADR: IPSEY) today announced the appointment of Aymeric Le Chatelier as Executive Vice President, Chief Financial Officer effective as of 3 November 2014. He will report directly to Marc d...
Biopharmaceuticals, Personnel
Ipsen

Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs

周五, 10/10/2014 - 13:11
WINNERSH, UNITED KINGDOM--(Healthcare Sales & Marketing Network) - Vernalis plc (LSE: VER) today announces it has opened its US office in Berwyn, Pennsylvania and has strengthened its US Executive team with the appointment of Dr Pascal Borderies, as SVP Me...
Biopharmaceuticals, Personnel
Vernalis

Angiotech Appoints John Barr as CEO

周四, 10/09/2014 - 13:39
VANCOUVER, Oct. 9, 2014 -- (Healthcare Sales & Marketing Network) - Angiotech Pharmaceuticals, Inc. announced today that its Board of Directors has appointed John R. Barr as Chief Executive Officer. Mr. Barr brings over 35 years of medical device and oper...
Biopharmaceuticals, Personnel
Angiotech Pharmaceuticals

Neovasc Receives FDA Conditional Approval to Initiate TIARA-I Trial in US: A Multinational, Multicenter Early Feasibility Trial of the Tiara(TM) Transcatheter Mitral Valve

周四, 10/09/2014 - 13:37
VANCOUVER , Oct. 9, 2014 (Healthcare Sales & Marketing Network) - Neovasc Inc. ("Neovasc" or the "Company") (NVCN) (NVC.TO) today announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. F...
Devices, Interventional Cardiology, FDA
Neovasc, Tiara, transcatheter mitral valve, mitral valve

Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion

周四, 10/09/2014 - 13:27
Auxilium Shareholders to Receive $33.25 Per Share Combination Designed to Create Leading Specialty Healthcare Company with Expanded Platform for Future Growth Addition of Auxilium's Leading Men's Health Products and Development Portfolio Expected to ...
Biopharmaceuticals, Mergers & Acquisitions
Endo International, Auxilium Pharmaceuticals, XIAFLEX

Lombard Medical's Aorfix(TM) Endovascular Stent Graft Adopted by Surgeons at Veteran Affairs Medical Centers

周四, 10/09/2014 - 13:17
Highlights Value of Uniquely Broad Label for Treating Patients With Abdominal Aortic Aneurysms, Including Those With Complex Anatomies IRVINE, Calif. and LONDON, Oct. 9, 2014 -- (Healthcare Sales & Marketing Network) -- Lombard Medical, Inc. (EVAR), a m...
Devices, Interventional
Lombard Medical, endovascular aneurysm repair, Aorfix , AAA

Cortendo Appoints Robert Lutz as Chief Business Officer

周四, 10/09/2014 - 13:06
GÖTEBORG, Sweden & RADNOR, Penn.--(Healthcare Sales & Marketing Network)--Cortendo AB [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders, announced the appointment of Robert Lutz as Chief Business Office...
Biopharmaceuticals, Personnel
Cortendo

EndoGastric Solutions Announces Publication of Study Demonstrating Benefits of TIF Procedure in Controlling GERD Symptoms

周三, 10/08/2014 - 13:19
Prospective, Randomized Study Showed Durability of Clinical Outcomes in the TIF Group and Improved Control of GERD symptoms in the Crossover Group SAN MATEO, Calif.--(Healthcare Sales & Marketing Network)--EndoGastric Solutions® (EGS), a leader in e...
Devices, Gastroenterology
EndoGastric Solutions, Transoral Incisionless Fundoplication, GERD

Masimo Announces CE Mark of the 11th Rainbow(R) Parameter - ORI(TM), Oxygen Reserve Index(TM)

周三, 10/08/2014 - 13:11
First Noninvasive & Continuous Parameter to Provide Insight Into Oxygen Reserve in Patients Receiving Supplemental Oxygen NEUCHATEL, SWITZERLAND--(Healthcare Sales & Marketing Network) - Masimo (NASDAQ: MASI) today announced CE Mark and limited market r...
Devices, Monitoring, Regulatory
Masimo, Oxygen Reserve Index

Kubtec(R) Announces FDA Approval of World’s First Breast Specimen Tomosynthesis System During Breast Cancer Awareness Month

周三, 10/08/2014 - 13:03
MOZART® with TomoSpec®: 3D Specimen Imaging Technology From Kubtec MILFORD, Conn.--(Healthcare Sales & Marketing Network)--Kubtec, the foremost developer of digital specimen radiography systems, marks the start of Breast Cancer Awareness Month w...
Devices, FDA
Kubtec, MOZART, TomoSpec , tomosynthesis

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong